Klotho Neurosciences, Inc.(KLTO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KLTO Klotho Neurosciences, Inc.

交易中 03-17 13:28:33 EDT

0.5242

+0.0000

0.00%

最高0.5242	最低0.5242	成交量0.00
今开0.5242	昨收0.5242	日振幅0.00%
总市值5,661万	流通市值5,142万	总股本1.08亿
成交额0.00	换手率0.00%	流通股本9,809万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KLTO","market":"US","secType":"STK","nameCN":"Klotho Neurosciences, Inc.","latestPrice":0.5242,"timestamp":1773768513588,"preClose":0.5242,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":98090000,"shares":108000000,"eps":-0.304642,"marketStatus":"交易中","change":0,"latestTime":"03-17 13:28:33 EDT","open":0.5242,"high":0.5242,"low":0.5242,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.304642,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773777600000},"marketStatusCode":2,"symbolChange":{"newSymbol":"GRML","executeDate":"2026-03-12"},"adr":0,"exchange":"NASDAQ","adjPreClose":0.5242,"volumeRatio":0},"requestUrl":"/m/hq/s/KLTO","defaultTab":"news","newsList":[{"id":"2618990237","title":"Klotho Neurosciences, Inc.盘中异动 股价大涨5.07%报0.495美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618990237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618990237?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:31","pubTimestamp":1773149471,"startTime":"0","endTime":"0","summary":"北京时间2026年03月10日21时31分，Klotho Neurosciences, Inc.股票出现波动，股价急速上涨5.07%。截至发稿，该股报0.495美元/股，成交量17.9715万股，换手率0.17%，振幅0.96%。Klotho Neurosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。Klotho Neurosciences, Inc.公司简介：Klotho Neurosciences Inc致力于开发治疗慢性疾病的基本药物：癌症、心血管疾病和神经退行性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031021311197ac1878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031021311197ac1878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRML","KLTO"],"gpt_icon":0},{"id":"1113700901","title":"Klotho Neurosciences宣布更名为Greenland Mines Ltd.，纳斯达克股票代码将于2026年3月12日起变更为Grml","url":"https://stock-news.laohu8.com/highlight/detail?id=1113700901","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113700901?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:31","pubTimestamp":1773059513,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences公司正式宣布，将进行品牌重塑，更名为Greenland Mines Ltd.。此次变更将于2026年3月12日正式生效。与此同时，公司在纳斯达克交易所的股票交易代码也将同步更改为“Grml”。这一战略举措标志着公司业务方向的重大调整与全新开端。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRML","KLTO"],"gpt_icon":0},{"id":"1110162728","title":"Klotho Neurosciences收购Greenland Mines Corp.，掌控全球最具战略价值新兴贸易走廊内价值680亿美元的钯金、黄金、白金及关键矿产矿床","url":"https://stock-news.laohu8.com/highlight/detail?id=1110162728","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110162728?lang=zh_cn&edition=full","pubTime":"2026-03-04 21:09","pubTimestamp":1772629769,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc. 已完成对Greenland Mines Corp.的收购，此举使其成功获得了对一处估值高达680亿美元的矿产资源的控制权。该矿床富含钯、金、铂等贵金属以及多种关键矿物，且地理位置极为优越，坐落于全球最具战略重要性的新兴贸易通道之上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"1147360700","title":"Klotho Neurosciences Inc. 与 Greenland Mines Corp. 达成协议，后者预计将持有其完全稀释后总股本的93%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147360700","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147360700?lang=zh_cn&edition=full","pubTime":"2026-03-04 21:02","pubTimestamp":1772629330,"startTime":"0","endTime":"0","summary":"根据最新达成的协议，Greenland Mines Corp. 预计将持有 Klotho Neurosciences Inc. 完全稀释后总股本的93%。这一重大股权变动凸显了 Greenland Mines Corp. 对 Klotho Neurosciences Inc. 未来发展前景的强劲信心，同时也标志着 Klotho Neurosciences Inc. 的股权结构将发生显著变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"1120217675","title":"Klotho Neurosciences签署证券购买协议，将发行3460万股股票——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1120217675","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120217675?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:06","pubTimestamp":1771931184,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc. (简称：KLTO) 已正式签订一项证券购买协议，根据向美国证券交易委员会（SEC）提交的最新文件显示，该公司计划发行总计3460万股普通股。\n此次股权融资旨在为公司后续的神经科学领域研发及运营活动提供资金支持。市场分析人士指出，这类融资行为通常反映了公司对自身研发管线进展的信心以及对未来业务扩张的资金需求。不过，发行新股也可能对现有股东的股权产生一定稀释效应，具体影响需视最终发行条款及市场认购情况而定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2612281891","title":"Klotho Neurosciences, Inc.盘中异动 快速拉升5.42%报0.228美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612281891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612281891?lang=zh_cn&edition=full","pubTime":"2026-02-19 01:50","pubTimestamp":1771437009,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日01时50分，Klotho Neurosciences, Inc.股票出现异动，股价大幅上涨5.42%。Klotho Neurosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Sensei Biotherapeutics, Inc.、Moolec Science Sa C/Wts 30/01/2028、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Moolec Science Sa、Sensei Biotherapeutics, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为863.48%、781.19%、192.65%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Sensei Biotherapeutics, Inc.、Moolec Science Sa，振幅分别为160.33%、108.11%、106.99%。Klotho Neurosciences, Inc.公司简介：Klotho Neurosciences Inc致力于开发治疗慢性疾病的基本药物：癌症、心血管疾病和神经退行性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219015009a4b0f7cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219015009a4b0f7cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"1193996753","title":"Klotho Neurosciences Inc - 提交出售和转售最多3490万普通股的招股说明书","url":"https://stock-news.laohu8.com/highlight/detail?id=1193996753","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193996753?lang=zh_cn&edition=full","pubTime":"2025-12-06 06:20","pubTimestamp":1764973231,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences Inc - 提交出售和转售最多3490万普通股的招股说明书","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2586934445","title":"Klotho Neurosciences, Inc.盘中异动 早盘大幅拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586934445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586934445?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:42","pubTimestamp":1763995372,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时42分，Klotho Neurosciences, Inc.股票出现异动，股价快速上涨5.40%。Klotho Neurosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃，换手率分别为471.62%、354.11%、46.51%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Enlivex Therapeutics Ltd.、Bioatla, Inc.，振幅分别为38.86%、31.22%、16.60%。Klotho Neurosciences, Inc.公司简介：Klotho Neurosciences Inc致力于开发治疗慢性疾病的基本药物：癌症、心血管疾病和神经退行性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242242539517aa91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242242539517aa91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2585715911","title":"Klotho Neurosciences, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585715911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585715911?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:06","pubTimestamp":1763744799,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时06分，Klotho Neurosciences, Inc.股票出现波动，股价快速上涨5.15%。Klotho Neurosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Osr Holdings, Inc.、Pasithea Therapeutics Corp.、Psyence Biomedical Ltd.较为活跃，换手率分别为441.05%、20.33%、20.27%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为63.22%、49.71%、47.00%。Klotho Neurosciences, Inc.公司简介：Klotho Neurosciences Inc致力于开发治疗慢性疾病的基本药物：癌症、心血管疾病和神经退行性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122010639a70976a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122010639a70976a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"1123209174","title":"Klotho Neurosciences Inc签署价值3亿美元的韩国制药公司授权及合作开发协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1123209174","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123209174?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:34","pubTimestamp":1759235649,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences Inc与韩国制药公司签署了价值3亿美元的对外授权和合作开发合作协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"1151730193","title":"Klotho Neurosciences签署意向书收购Turn Biotechnologies精选资产，以3亿美元全球制药合作为支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=1151730193","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151730193?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:33","pubTimestamp":1759235639,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences签署意向书收购Turn Biotechnologies精选资产，以3亿美元全球制药合作为支撑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.klothoneuro.com","stockEarnings":[{"period":"1week","weight":0.1127},{"period":"1month","weight":1.373},{"period":"3month","weight":0.3441},{"period":"6month","weight":-0.0804},{"period":"1year","weight":0.8497},{"period":"ytd","weight":0.8138}],"compareEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":-0.0187},{"period":"3month","weight":-0.0145},{"period":"6month","weight":0.0149},{"period":"1year","weight":0.1887},{"period":"ytd","weight":-0.0189}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Klotho Neurosciences, Inc.于2021年3月16日在特拉华州注册成立。该公司专门开发获得专利的新型疾病改良技术，包括治疗神经退行性疾病和与年龄相关疾病的关键发展。ANEW正在开发尖端的蛋白质、基因和细胞疗法，以治疗与年龄相关的病理，如阿尔茨海默病和帕金森病、ALS和罕见的神经退行性疾病。其他资产包括多项平台技术的全球权利，其中包括一个已被证明可以调节饥饿、食物摄入和体重减轻的黑皮质素肽库，以及ANEW名为Nanoject的干纳米颗粒粉末注射系统，这是一种用于安全、无痛地自我注射胰岛素、GLP-1激动剂、生育药物和许多其他药物、疫苗和蛋白质分子的专利医疗设备。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.06215},{"month":2,"riseRate":0.5,"avgChangeRate":0.188375},{"month":3,"riseRate":0.5,"avgChangeRate":-0.036461},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.218192},{"month":5,"riseRate":0.5,"avgChangeRate":-0.006199},{"month":6,"riseRate":0.75,"avgChangeRate":1.150026},{"month":7,"riseRate":0.25,"avgChangeRate":-0.147403},{"month":8,"riseRate":0.25,"avgChangeRate":-0.147672},{"month":9,"riseRate":0.5,"avgChangeRate":-0.1464},{"month":10,"riseRate":0.5,"avgChangeRate":-0.038644},{"month":11,"riseRate":0.25,"avgChangeRate":-0.077658},{"month":12,"riseRate":0.5,"avgChangeRate":-0.032823}],"exchange":"NASDAQ","name":"Klotho Neurosciences, Inc.","nameEN":"Klotho Neurosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Klotho Neurosciences, Inc.(KLTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Klotho Neurosciences, Inc.(KLTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Klotho Neurosciences, Inc.,KLTO,Klotho Neurosciences, Inc.股票,Klotho Neurosciences, Inc.股票老虎,Klotho Neurosciences, Inc.股票老虎国际,Klotho Neurosciences, Inc.行情,Klotho Neurosciences, Inc.股票行情,Klotho Neurosciences, Inc.股价,Klotho Neurosciences, Inc.股市,Klotho Neurosciences, Inc.股票价格,Klotho Neurosciences, Inc.股票交易,Klotho Neurosciences, Inc.股票购买,Klotho Neurosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Klotho Neurosciences, Inc.(KLTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Klotho Neurosciences, Inc.(KLTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}